SCWorx Corp. Reports Q1 2024 Financial Results: A Mixed Bag Amidst Challenges
SCWorx Corp. (formerly SCW FL Corp.), a key player in healthcare technology solutions, has released its financial report for the first quarter of 2024. While the company continues to provide critical data management solutions to healthcare providers, recent results indicate ongoing challenges, particularly influenced by the COVID-19 pandemic and a significant restructuring effort.
1. Overview of the Company
Founded in 2016 and headquartered in Florida, SCWorx specializes in data content and services that enhance the interoperability of information within the healthcare sector. The company’s software solutions are designed to streamline healthcare processes and improve data management for hospitals and healthcare providers.
Key Events: Reverse Stock Split
In a notable strategic move, SCWorx executed a 1-for-15 reverse stock split on October 6, 2023, to consolidate its shares and potentially enhance its stock price. The reverse split took effect on October 11, 2023, and reflects the company's efforts to maintain compliance with listing requirements while aiming to improve investor perception.
2. Financial Performance for Q1 2024
Income Statement Analysis
For the three months ending March 31, 2024, SCWorx reported revenue of $812,099, a decline of $185,350 (approximately 18.6%) compared to the same period in 2023, where revenue stood at $997,449. The decrease in revenue underscores the ongoing impact of the pandemic on customer acquisition and business expansion.
Cost of revenues also decreased, totaling $603,465 in Q1 2024, down by $85,997 from $689,462 in Q1 2023. This reduction indicates an effort to manage operational costs despite declining revenues.
Operating expenses saw a substantial decrease to $387,090, down from $707,404 in the previous year. This 45.2% reduction is indicative of the company’s strategic cost-cutting measures amid challenging market conditions.
Despite these efforts, SCWorx incurred a net loss of $178,659 for the quarter, a significant improvement from the net loss of $399,890 reported in Q1 2023.
| May 2023 | Oct 2024 | |
|---|---|---|
Net Income | -1.62M | -3.75M |
Profit | -1.62M | -3.75M |
Net Income Continuing | -1.62M | -3.75M |
Pretax Income | -1.62M | -3.75M |
Non-operating Income | 139.5K | -2.53M |
Operating Income | -1.76M | -1.22M |
Revenue | 4.00M | 3.61M |
Costs and Expenses | 5.76M | 4.84M |
Cost of Revenue | 689.4K | 2.44M |
Operating Expenses | 5.07M | 2.39M |
Selling, General & Administrative | 3.14M | 659.9K |
Other Operating Expenses | 1.92M | 1.73M |
Liquidity and Cash Flow
SCWorx’s liquidity position remains concerning. The company reported a cash outflow from operating activities of approximately $59,000 for Q1 2024, primarily driven by the net loss. The company did manage to generate cash inflows from financing activities amounting to $7,647, which consisted of proceeds from accounts payable and accrued liabilities.
The net change in cash for the quarter was a decrease of $51,830, reflecting ongoing operational challenges.
| May 2023 | Oct 2024 | |
|---|---|---|
Net Change in Cash | 241.4K | -210.1K |
Net Cash from Operating Activities | -464.5K | -884.9K |
Operating Profit | -1.62M | -3.75M |
Adjustment to Operating Profit | 1.15M | 2.87M |
Net Cash from Investing Activities | 0 | 165K |
Other Investing Activities | 0 | 165K |
Net Cash from Financing Activities | 705.9K | 509.8K |
Debt | 0 | -49.74K |
Equity Issuance/Repurchase | 725.0K | 572.9K |
Other Financing Activities | -19.09K | -13.29K |
3. Balance Sheet Highlights
As of March 31, 2024, SCWorx reported total assets of $6.34 million, a marked decrease from $9.27 million in the previous year. This decline is attributed to reduced cash reserves and receivables, which have been impacted by the company’s struggles to secure new customers and maintain existing relationships in a tumultuous market.
Total liabilities stood at $2.63 million, with a significant portion composed of current liabilities. The company's equity has also been affected, with total equity at $3.70 million, down from $6.52 million in Q1 2023. This decline in equity is primarily due to accumulated losses over the past quarters.
| May 2023 | Oct 2024 | |
|---|---|---|
Total Assets | 9.27M | 6.34M |
Total Current Assets | 910.2K | 500.8K |
Cash and Equivalents | 249.7K | 39.60K |
Accounts Receivable | 344.4K | 391.0K |
Prepaid Expenses | 316.0K | 70.13K |
Total Non-current Assets | 8.36M | 5.84M |
Intangible Assets | 8.36M | 5.84M |
Total Liabilities and Equity | 9.27M | 6.34M |
Total Liabilities | 2.75M | 2.63M |
Total Current Liabilities | 2.62M | 2.63M |
Accounts Payable and Accrued Liabilities | 153.8K | 1.91M |
Current Debt | 0 | 70.99K |
Current Deferred Revenue | 735.3K | 410.3K |
Other Current Liabilities | 1.73M | 244.4K |
Total Non-current Liabilities | 128.6K | 0 |
Long-term Debt | 128.6K | 0 |
Total Equity and Non-controlling Interests | 6.52M | 3.70M |
Total Equity | 6.52M | 3.70M |
4. Management Commentary
Management has expressed concern regarding the company's ability to continue as a going concern. The ongoing impacts of the COVID-19 pandemic have hampered growth prospects and customer acquisition efforts, which are critical for SCWorx’s recovery. The company remains committed to its mission of providing innovative data management solutions to the healthcare sector but acknowledges the need for strategic adjustments moving forward.
5. Conclusion
The Q1 2024 financial results for SCWorx Corp. reflect a company in transition, grappling with significant challenges yet showing signs of improvement in net loss figures. With a keen focus on cost management and operational efficiency, SCWorx aims to navigate the turbulent waters of the healthcare technology market. As the company works to stabilize its financial standing and enhance its service offerings, stakeholders will be closely watching for signs of recovery and sustained growth in the upcoming quarters.
